A new study from researchers at Sanford Burnham Prebys and Eli Lilly and Company describes the science behind an autoimmune disease treatment in a Phase 2 clinical trial.

Many in the county are facing barriers to adopting solar energy, but Sanford Burnham Prebys is leading the charge with a $2.5 million investment in solar power.

The annual event aims to foster greater diversity in biomedical research and shine a spotlight on the next generation of scientific leaders.

A new educational program at Sanford Burnham Prebys has welcomed a diverse group of early-career scientists to learn how to transform research discoveries into treatments for human diseases.

Researchers from Sanford Burnham Prebys and the Chinese University of Hong Kong have developed a computational approach to predict whether a person with type 2 diabetes will develop kidney disease.

The event celebrated 16 years of progress at the Center and connected scientists with the people most impacted by their work.

One of the biggest goals of immunotherapy is to reverse T cell exhaustion to boost the immune system’s ability to destroy cancerous cells. Researchers at Sanford Burnham Prebys studying melanoma have found a new way to make this happen.

Sanford Burnham Prebys researchers have a new way of looking at childhood brain tumors—and it’s revealing new avenues to treat them.

With the help of a new grant from the U.S. Department of Defense for more than $1.7 million, Associate Professor Charles Spruck, Ph.D., will advance an innovative therapeutic approach for metastatic prostate cancer.

April is National Stress Awareness Month, so we talked to Assistant Professor Caroline Kumsta about how she uses worms to study the cellular stress responses that occur with aging.

To honor National Minority Health Month, we spoke to Svasti Haricharan about her work, who recently published a paper describing some of the shortfalls of the current research focusing on cancer disparities.

The mission of the AACR Academy is to recognize and honor distinguished scientists whose scientific contributions have propelled significant innovation and progress against cancer.